United Therapeutics Corp (UTHR): Shareholders' Equity
$7.10B
As of 2025-12-31
$6.40B
As of 2026-06-30
+13.9%
3-year compound annual growth
+15.9%
5-year compound annual growth
+16.1%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.10B | +10.1% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $6.44B | +7.7% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $5.98B | +24.8% | 2026-02-25, Balance as of period end |
| 2022-12-31 | $4.80B | +21.2% | 2025-02-26, Balance as of period end |
| 2021-12-31 | $3.96B | +16.6% | 2024-02-21, Balance as of period end |
| 2020-12-31 | $3.40B | +22.1% | 2023-02-22, Balance as of period end |
| 2019-12-31 | $2.78B | -0.3% | 2022-02-24, Balance as of period end |
| 2018-12-31 | $2.79B | +32.7% | 2021-02-24, Balance as of period end |
| 2017-12-31 | $2.10B | +13.5% | 2020-02-26, Balance as of period end |
| 2016-12-31 | $1.85B | +16.5% | 2019-02-27, Balance as of period end |
| 2015-12-31 | $1.59B | +27.9% | 2018-02-21, Balance as of period end |
| 2014-12-31 | $1.24B | -1.3% | 2017-02-22, Balance as of period end |
| 2013-12-31 | $1.26B | +16.2% | 2016-02-25, Balance as of period end |
| 2012-12-31 | $1.08B | +14.3% | 2015-02-24, Balance as of period end |
| 2011-12-31 | $948.49M | +7.3% | 2014-02-25, Balance as of period end |
| 2010-12-31 | $883.89M | +35.4% | 2013-02-26, Balance as of period end |
| 2009-12-31 | $653.01M | +17.6% | 2012-02-28, Balance as of period end |
| 2008-12-31 | $555.33M | n/a | 2011-02-24, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| United Therapeutics Corp (UTHR) | 2025-12-31 | $7.10B | +10.1% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $6.09B | +7.6% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | -$70.79M | n/m |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $789.18M | n/m |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $2.94B | -32.0% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $9.71B | -6.1% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $4.32B | +5.5% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $1.14B | -25.3% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.55B | +7.4% |
Compare UTHR, BMRN, AMRX, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗